Stock Information
Aldeyra Therapeutics Inc (ALDX)
Ticker Symbol: ALDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $327.03 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.7217
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -72.25%
Latest News
-
Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference
Wed, Feb 25, 2026 8:29 PM
Key Financials
Financial data not available